20 results on '"Arhin, Francis"'
Search Results
2. In vitro activity of oritavancin and comparator agents against staphylococci, streptococci and enterococci from clinical infections in Europe and North America, 2011–2014
3. Time–kill kinetics of oritavancin and comparator agents against Streptococcus pyogenes
4. Comparative activity of oritavancin against meticillin-resistant Staphylococcus aureus (MRSA) bloodstream isolates from Geneva University Hospital
5. In vitro activities of oritavancin and comparators against meticillin-resistant Staphylococcus aureus (MRSA) isolates harbouring the novel mecC gene
6. In vitro stepwise selection of reduced susceptibility to lipoglycopeptides in enterococci.
7. Activity of oritavancin and comparators in vitro against standard and high inocula of Staphylococcus aureus
8. Longitudinal analysis of the in vitro activity profile of oritavancin and comparator glycopeptides against Gram-positive organisms from Europe: 2005–2008
9. Oritavancin retains bactericidal activity in vitro against standard and high inocula of heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA)
10. Correlation between oritavancin and vancomycin minimum inhibitory concentrations in staphylococci
11. Impact of human serum albumin on oritavancin in vitro activity against Staphylococcus aureus
12. Newly defined in vitro quality control ranges for oritavancin broth microdilution testing and impact of variation in testing parameters
13. A new class of small molecule RNA polymerase inhibitors with activity against Rifampicin-resistant Staphylococcus aureus
14. Comparative in vitro activity of oritavancin against recent, genetically diverse, community-associated meticillin-resistant Staphylococcus aureus (MRSA) isolates
15. Supplier sustainability performance evaluation and selection: A framework and methodology.
16. Comparative in vitro activity of oritavancin and other agents against methicillin-susceptible and methicillin-resistant Staphylococcus aureus.
17. Triaminotriazine DNA helicase inhibitors with antibacterial activity
18. In vitro activity of Oritavancin against gram-positive pathogens isolated in Canadian hospital laboratories from 2011 to 2015.
19. Synthesis and in vitro evaluation of bisphosphonated glycopeptide prodrugs for the treatment of osteomyelitis
20. Bisphosphonated fluoroquinolone esters as osteotropic prodrugs for the prevention of osteomyelitis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.